Pfizer 2012 Annual Report Download - page 56

Download and view the complete annual report

Please find page 56 of the 2012 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 121

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
2012 Financial Report
55
As of December 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2012 2011
Assets
Cash and cash equivalents $10,389 $3,182
Short-term investments 22,319 23,270
Accounts receivable, less allowance for doubtful accounts, 2012—$374; 2011—$226 12,378 13,058
Inventories 7,063 6,610
Taxes and other current assets 9,196 9,380
Assets of discontinued operations and other assets held for sale 70 5,317
Total current assets 61,415 60,817
Long-term investments 14,149 9,814
Property, plant and equipment, less accumulated depreciation 14,461 15,921
Goodwill 44,672 44,569
Identifiable intangible assets, less accumulated amortization 46,013 51,184
Taxes and other noncurrent assets 5,088 5,697
Total assets $185,798 $188,002
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2012—$2,449; 2011—$6 $6,424 $4,016
Accounts payable 4,264 3,678
Dividends payable 1,734 1,796
Income taxes payable 1,010 1,009
Accrued compensation and related items 2,046 2,120
Other current liabilities 13,141 15,066
Liabilities of discontinued operations —1,224
Total current liabilities 28,619 28,909
Long-term debt 31,036 34,926
Pension benefit obligations 7,830 6,355
Postretirement benefit obligations 3,493 3,344
Noncurrent deferred tax liabilities 21,593 18,861
Other taxes payable 6,610 6,886
Other noncurrent liabilities 4,939 6,100
Total liabilities 104,120 105,381
Commitments and Contingencies
Preferred stock, without par value, at stated value; 27 shares authorized; issued:
2012—967; 2011—1,112 39 45
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2012—8,956;
2011—8,902 448 445
Additional paid-in capital 72,608 71,423
Employee benefit trusts (1) (3)
Treasury stock, shares at cost: 2012—1,680; 2011—1,327 (40,121) (31,801)
Retained earnings 54,240 46,210
Accumulated other comprehensive loss (5,953)(4,129)
Total Pfizer Inc. shareholders’ equity 81,260 82,190
Equity attributable to noncontrolling interests 418 431
Total equity 81,678 82,621
Total liabilities and equity $185,798 $188,002
See Notes to Consolidated Financial Statements, which are an integral part of these statements.